Ibrutinib has 'unprecedented' impact on mantle cell lymphoma

Researchers from The University of Texas MD Anderson Cancer Center presented interim findings of the multi-center Phase 2 study December 16 at the 54th American Society of Hematology Annual Meeting and Exposition.

http://www.sciencedaily.com/releases/2012/12/121214190837.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fdiseases_and_conditions+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Diseases+and+Conditions%29